Aripiprazole and Oral Dosing
Links shared publicly online about this topic
Symptomatic Bradycardia with Oral Aripiprazole and Oral Ziprasidone (April) -- Snarr et al., 10.1345/aph.1M621 -- The Annals of Pharmacotherapy
theannals.com — “Symptomatic Bradycardia with Oral Aripiprazole and Oral Ziprasidone (April) -- Snarr et al., 10.1345/aph.1M621 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on March 10, 2010 at 3:30 am By:
Symptomatic Bradycardia with Oral Aripiprazole and Oral Ziprasidone (April): OBJECTIVE: To describ... http://bit.ly/bmuB8Q
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
medicalnewstoday.com — “The european medicines agency has been formally notified by otsuka pharmaceutical europe ltd of its decision to withdraw its application for an extension of indication for the centrally authorised” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 11:41 am By:
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripipra.. http://bit.ly/1QCH4R
Adding a low dose atypical antipsychotic drug to a... [Prog Neuropsychopharmacol Biol Psychiatry. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 19, 2010 at 2:45 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Aripiprazole antidepressant augmentation produces rapid increase in BDNF in treatment-resistant depression. http://ht.ly/1MQYN
Changes In Bone Density In Oral Contraceptive Users Depends On Age And Hormone Dose
medicalnewstoday.com — “Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institu” View full resource at medicalnewstoday.com
Most Recently Shared on July 20, 2011 at 10:03 am By:
Debby Verville Health Advocate
Changes In Bone Density In Oral Contraceptive Users Depends On Age And Hormone Dose: Birth control pills may red... http://bit.ly/qJWToQ
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of schizophrenia, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY® for the treatment of a number of central nervo” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 6:00 pm By:
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia: Alkermes, Inc... http://bit.ly/kd2y2o
Precise Dose for Peanut Allergy Treatment- Oral Immunotherapy | BlogHer
blogher.com — “Precise Dose for Peanut Allergy Treatment- Oral Immunotherapy | BlogHer” View full resource at blogher.com
Most Recently Shared on March 2, 2011 at 7:57 am By:
Precise Dose for Peanut Allergy Treatment- Oral Immunotherapy http://bit.ly/hQLYnz
Chewable Low-Dose Oral Contraceptive approved - MPR
empr.com — “Watson announced that the FDA has approved a low dose oral contraceptive, which combines a 24-day active hormone regimen (0.8mg norethindrone and 25mcg ethinyl estradiol) with four tablets containing 75mg of ferrous fumarate, in chewable form.” View full resource at empr.com
Most Recently Shared on December 27, 2010 at 2:41 pm By:
Physician Assistants Health News Feed
Chewable Low-Dose Oral Contraceptive approved: http://bit.ly/gyjucM
Chewable Low-Dose Oral Contraceptive approved - MPR
empr.com — “Watson announced that the FDA has approved a low dose oral contraceptive, which combines a 24-day active hormone regimen (0.8mg norethindrone and 25mcg ethinyl estradiol) with four tablets containing 75mg of ferrous fumarate, in chewable form.” View full resource at empr.com
Most Recently Shared on December 23, 2010 at 4:02 pm By:
MPR News: Chewable Low-Dose Oral Contraceptive approved: Watson announced that the FDA has approved a low dose o... http://bit.ly/hMtdAh
New Dosing Options for Welchol for Oral Suspension Approved - MPR
empr.com — “The FDA has approved the supplemental New Drug Application for Welchol (colesevelam HCl; Daiichi Sankyo) for Oral Suspension to be mixed with fruit juice or diet soft drinks.” View full resource at empr.com
Most Recently Shared on July 25, 2011 at 8:55 pm By:
MPR News: New Dosing Options for Welchol for Oral Suspension Approved: The FDA has approved the supplemental New... http://bit.ly/oFbCIU
What Dose of Oral Vitamin D Do You Need to Prevent Cancer?
articles.mercola.com — “New research confirms that higher dosage of vitamin D is needed for you to experience its full benefits.” View full resource at articles.mercola.com
Most Recently Shared on March 10, 2011 at 6:44 am By:
Chiropractor Peoria CAM, Chiropractor, and Doctor
What Dose of Oral Vitamin D Do You Need to Prevent Cancer? http://bit.ly/hkjU2J
Metoprolol Succinate Oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
webmd.com — “Find patient medical information for Metoprolol Succinate Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings” View full resource at webmd.com
Most Recently Shared on January 28, 2010 at 4:12 pm By:
Nurses - when corners are cut and some doses will be missed (make sure the pt. gets their Metoprolol) http://tinyurl.com/7y32bo
Celebrex Oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
webmd.com — “Find patient medical information for Celebrex Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings” View full resource at webmd.com
Most Recently Shared on November 12, 2009 at 5:50 pm By:
@smartin511 Go to - http://snurl.com/t7c47 and scroll to bottom. There's a link to MedWatch from WebMD page. #fdasm
Unigene Doses First Patient In Phase 2 Oral PTH Study For The Treatment Of Osteoporosis In Postmenopausal Women
medicalnewstoday.com — “Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced the dosing of the first subject in a Phase 2 study wi” View full resource at medicalnewstoday.com
Most Recently Shared on March 17, 2011 at 9:30 am By:
Debby Verville Health Advocate
Unigene Doses First Patient In Phase 2 Oral PTH Study For The Treatment Of Osteoporosis In Postmenopausal Women:... http://bit.ly/fyeSEd
JAMA -- High-Dose Oral Vitamin D Supplementation and Risk of Falls in Older Women, August 25, 2010, Mak 304 (8): 854
jama.ama-assn.org — “JAMA is a highly cited weekly medical journal that publishes peer-reviewed original medical research findings and editorial opinion” View full resource at jama.ama-assn.org
Most Recently Shared on August 24, 2010 at 9:00 pm By:
High-Dose Oral Vitamin D Supplementation and Risk of Falls in Older Women [Letters] http://bit.ly/b86OMI
TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing In Diabetic Foot Infection Met Primary Endpoints
medicalnewstoday.com — “TaiGen Biotechnology Co., Ltd. announced the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinic” View full resource at medicalnewstoday.com
Most Recently Shared on March 13, 2010 at 2:06 pm By:
MNT Pharma News Health News and Pharma
TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing In Diabetic Foot Infection Met Primary Endpoints http://mnt.to/3ySW
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
-
MNT Mental Health
The latest mental health news published daily. Articles from research centers, universities and prestigious journals.
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
Advertisement
